Molecular mechanisms in cell-mediated cytotoxicity

Cell

Volumn 90, Issue 1, 1997, Pages 13-18

  Moretta, Alessandro ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GRANZYME A;

APOPTOSIS; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; EXOCYTOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0031458812     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80309-8     Document Type: Conference Paper

References (49)

1. Ahn, K., Angulo, A., Ghazal, P., Peterson, P.A., Yang, Y., and Fruh, K. (1996). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93, 10990-10995.
2. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen G., Thornberry, N.A., Wong, W.W., and Yuan, J.Y. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
3. Andersson, M., Paabo, S., Nilsson, T., and Peterson, P.A. (1985). Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43, 215-222.
4. Beck, S., and Barrell, B.G. (1988). Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 333, 269-272.
5. Boldin, M.P., Goncharov, T.M., Golstev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT/FADD-interacting protease, in Fas/APO-1 and TNF-receptor-induced cell death. Cell 85, 803-815.
6. Bolhuis, R.L.H., Hoogenboom, H.R., and Gratama, J.W. (1996). Targeting of peripheral blood T lymphocytes. Springer Semin. Immunopathol. 18, 211-227.
7. Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M., Duan, D.R., King, L, Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR and CD95. Science 274, 990-992.
8. Correa, I., and Raulet, D.H. (1995). Binding of diverse peptides to MHC class I molecule inhibits target cell lysis by activated natural killer cells. Immunity 2, 61-67.
9. Coulie, P.G., Brichard, V., Van Pel, A., Wolfel, T., Shneider, J.,Traversari, C., Mattel, S., De Plaen, E., Lurquin, C., Szikora, J.P., et al. (1994). A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35-42.
10. Darmon, A.J., Nicholson, D.W., and Bleackley, R.C. (1995). Activation of the apoptotic protease CPP32 by cytotoxic T-cell derived granzyme B. Nature 377, 446-448.
11. Ebnet, K., Hausmann, M., Lehmann-Grube, F., Mullbacher, A., Kptf, M., Lamers, R., and Simon, M.M. (1995). Granzyme-A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 14, 4230-4239.
12. Eshhar, Z., Waks, T., Gross, G., and Shindler, D.G. (1993). Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci. USA 90, 720-724.
13. Fahnestock, M.J., Johnson, J.L., Feldman, R.M., Neveu, J.M., Lane, W.S., and Bjorkman, P.J. (1995). The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3, 583-590.
14. Froelich, C.J., Orth, K., Turbov, J., Seth, P., Gottlieb, R., Babior, B., Shah, G.M., Bleackley, R.C., Dixit, V.M., and Hanna, W. (1996). New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271, 29073-29079.
15. Fruh, K., Ahn, K., and Peterson, P.A. (1997). Inhibition of MHC class I antigen presentation by viral proteins. J. Mol. Med. 75, 18-27.
16. Golstein, P., Marguet, D., and Depraetere, V. (1995). Homology between Reaper and the cell death domains of Fas and TNFR1. Cell 81, 185-186.
17. Gross, G., and Eshhar, Z. (1992). Endowing T cells with antibody specificity using chimeric T cell receptors. FASEB J. 15, 3370-3378.
18. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
19. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R.M., and Hengartner, H. (1996). Molecular mechanisms of lymphocyte mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232.
20. Karre, K., and Welsh, M. (1997). Viral decoy vetoes killer cell. Nature 386, 446-447.
21. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P.G. (1997). Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6, 199-208.
22. Jans, D.A., Jans, P., Briggs, L.J., Button, V., and Trapani, J.A. (1996). Nuclear transport of granzyme B (fragmentin-2). Dependence on perforin in vivo and cytosolic factors in vitro. J. Biol. Chem. 271, 30781-30789.
23. Lazetic, S., Chang, C., Houchins, J.P., Lanier, L.L., and Phillips, J.H. (1996). Human Natural Killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157, 4741-4745.
24. Ljunggren H.-G., and Karre, K. (1990) In search of the "missing self". MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
25. Lopez Botet, M., Pérez-Villar, J.J., Carretero, M., Rodriguez, A., Melero, I., Bellon, T., Llano, M., and Navarro, F. (1997). Structure and function of CD94 C-type lectin receptor complex involved in recognition of HLA-class I molecules. Immunol. Rev. 155, 165-174.
26. Lowin, Hahne, M., Mattmann, C., and Tschopp, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652.
27. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M.C., and Moretta L. (1996). Receptors for HLA class I molecules in human Natural Killer cells. Annu. Rev. Immunol. 14, 619-648.
28. Moretta, A., Vitale, M., Sivori, S., Bottino, C., Morelli, L, Augugliaro, R., Barbaresi, M., Pende, D., Ciccone, E., Lopez-Botet, M., and Moretta, L. (1994). Human Natural Killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 180, 545-555.
29. Munz, C., Holmes, N., King, A., Loke, Y.W., Colonna, M., Schild, H., and Rammensee, H.-G. (1997). Human histocompatibility leukocyte antigen (HLA-G) molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185, 385-391.
30. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Schevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
31. Pazmany, L., Mandelboim, O., Valés-Ǵomez, M., Davis, D.M., Reyburn, H.T., and Strominger, J.L. (1996). Protection from natural killer cells - mediated lysis by HLA-G expression on target cells. Science 274, 792-795.
32. Pende, D., Sivori, S., Accame, L., Pareti, L., Falco, M., Geraghty, D., Le Bouteiller, P., Moretta, L., and Moretta, A. (1997). HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur. J. Immunol. 27, 1875-1880.
33. Perez-Villar, J.J., Melera, I., Navarro, F., Carretero, M., Bellon, T., Llano, M., Colonna, M., Geraghty, D.E., and Lopez-Botet, M. (1997). The CD94/NKG2A inhibitory receptor complex is involved in the Natural Killer cell-mediated recognition of cells expressing HLA-G1. J. Immunol. 158, 5736-5743.
34. Rénard, V., Cambiaggi, A., Vely, F., Blery, M., Olcese, L., Olivero, S., Bouchet, M., and Vivier, E. (1997). Transduction of cytotoxic signals in Natural Killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol. Rev. 155, 205-221.
35. Reyburn, H., Mandelboim, O., Valés-Goméz, M., Sheu, E.G., Pazmany, L., Davis, D.M., and Strominger, J.L. (1997). Human NK cells: their ligands, receptors and functions. Immunol. Rev. 155, 119-125.
36. Ropke, M., Hald, J., Guldberg, P., Zeuthen, J., Norgaard, L., Fugger, L., Svejgaard, A., Van der Burg, S., Nijman, H.W., Melief, C.J., and Claesson, M.H. (1996). Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc. Natl. Acad. Sci. USA. 93, 14704-14707.
37. Sarin, A., Williams, M.S., Alexander-Miller, M.A., Berzofsky, J.A., Zacharchuk, C.M., and Henkart, P. (1997). Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6, 206-215.
38. Shi, L., Mai, S., Israels, S., Browne, K.,Trapani, J.A.,and Greenberg, A.H. (1997). Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J. Exp. Med. 185, 855-866.
39. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L., and Moretta, A. (1996). CD94 functions as a natural killer cell inhibitory receptor for different HLA-CLASS-I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26, 2487-2492.
40. Spriggs, M.K. (1996). One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 1, 101-130.
41. Stancowski, I., Schindler, D.G., Waks, T., Yarden, Y., Sela, M., and Eshhar, Z. (1993). Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 11, 6577-6582.
42. Taupin, J.L., Tian, Q., Kedersha, N., Robertson, M., and Anderson, P. (1995). The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci. USA 92, 1629-1633.
43. Thale, R., Szepan, U., Hengel, H.,Geginat, G., Lucin, P., and Koszinowski, U.H. (1995). Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69, 6098-6105.
44. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J.L., Schroter, M., et al. (1997). Viral FLICE-inhibitor proteins (FLIPs) prevent apoptosis Induced by death receptors. Nature 386, 517-521.
45. Valiante, N.M., Lienert, K., Shilling, H.G., Smits, B.J., and Parham, P. (1997). Killer cell receptors: keeping pace with MHC class I evolution. Immunol. Rev. 155, 155-164.
46. White, K., Grether, M.E., Abrams, J.M., Young, L, Farrell, K., and Steller, H. (1994). Genetic control of programmed cell death in Drosophila. Science 264, 677-683.
47. Wiertz, E.J.H.J., Jones, T.R., Sun, L., Bogyo, M., Geuze, H.J., and Ploegh, H.L. (1996). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the ER to the cytosol. Cell 84, 769-779.
48. Yokoyama, W.M., and Seaman, W.E. (1993). The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11, 613-635.
49. York, I.A., Roop, C., Andrews, D.W., Riddell, S.R., Grahm, F.L., and Johnson, D.C. (1994). A cytosolic herpes simplex protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77, 525-535.